Share India Securities Limited has announced the partial redemption of its Non-Convertible Debentures (NCDs) issued on a private placement basis. The company informed both BSE Limited and National Stock Exchange of India Limited about this corporate action on March 11, 2026, in compliance with regulatory requirements.

Regulatory Disclosure Details

The disclosure was made pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. The communication was addressed to BSE Limited under scrip codes 540725, 976824, 976825, and 977430, and to National Stock Exchange of India Limited under the symbol SHAREINDIA.

NCD Redemption Specifics

The partial redemption affected two series of Non-Convertible Debentures, with significant reductions in their face values:

Transaction Timeline

The redemption process was completed efficiently, with all payments towards the partial redemption finalized by the company on March 10, 2026 at 10:49 p.m. The formal disclosure to stock exchanges followed the next day on March 11, 2026.

Corporate Compliance

The disclosure was signed by Vikas Aggarwal, Company Secretary & Compliance Officer (M. No. F5512), ensuring proper corporate governance protocols were followed. The digital signature was applied on March 11, 2026 at 10:34:16 +05'30', demonstrating the company's commitment to timely regulatory compliance and transparent communication with stakeholders.

Share India Securities Limited has announced the appointment of Mr. Arun Kumar Jain as Additional Director designated as Non-Executive Independent Director, following receipt of approvals from all major stock exchanges. The appointment became effective March 05, 2026, marking a significant addition to the company's board governance structure.

Exchange Approvals and Regulatory Compliance

The company received comprehensive approvals from multiple exchanges for Mr. Jain's appointment, with the final approval obtained on March 05, 2026 at 06:30 p.m. The appointment follows previous disclosure made on January 27, 2026 and complies with Regulations 30 and 51 of the SEBI Listing Obligations & Disclosure Requirements Regulations, 2015.

Appointment Terms and Duration

Mr. Arun Kumar Jain's appointment carries specific terms and conditions that align with regulatory requirements and corporate governance standards.

Professional Background and Expertise

Mr. Jain brings distinguished credentials to Share India Securities' board, with extensive experience in taxation, finance, and corporate governance. He holds M.Sc. and LL.B. degrees and has built an illustrious career in the Indian Revenue Service (IRS), serving in several senior positions within the Department of Revenue, including as Chairman of the Central Board of Direct Taxes (CBDT).

His professional expertise spans multiple critical areas:

• Taxation and regulatory compliance
• Accounts and finance management
• Corporate governance frameworks
• Corporate Social Responsibility (CSR)
• Strategic thinking and general management
• Capital markets operations
• Environmental, Health and Safety (EHS) standards

Current Board Positions

Mr. Jain currently serves as Non-Executive Independent Director on the Board of GHCL Limited since April 1, 2019, demonstrating his ongoing commitment to corporate governance excellence. The company confirmed that Mr. Jain is not related to any existing Director of Share India Securities and is not debarred from holding directorial positions by SEBI or any other regulatory authority.

Strategic Value Addition

The appointment is expected to strengthen Share India Securities' governance framework significantly. Mr. Jain's deep understanding of financial and regulatory matters positions him to provide valuable strategic guidance and effective oversight. His commitment to ethical practices and high governance standards will enhance the company's ability to navigate complex regulatory environments while safeguarding stakeholder interests.

The company will seek shareholder approval for this appointment within the stipulated three-month period, ensuring full compliance with regulatory requirements and corporate governance protocols.